News tagged ‘BreastCancer’ clear
- Dr. Ursula Matulonis commented on a study that found women with BRCA-1 mutations can reduce their risk of breast and ovarian cancer if they get their ovaries removed by age 35.
Tags: BreastCancer, OvarianCancer, Genetics
- Dr. Ann Partridge comments on a new study that shows women ages 40 to 59, who had yearly mammograms, received no added survival benefit up to 25 years later compared with those who skipped the screening.
- Dana-Farber researchers, including Dr. Kornelia Polyak, have developed a mathematical model to predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.
Tags: BreastCancer, Genomics
- Dr. Erica Mayer says up to 20 percent of breast cancers in women younger than 30 are associated with pregnancy, but the reasons why aren't well understood.
- "We've definitely had more women coming in to discuss their family history and whether genetic testing is appropriate after they heard about Angelina Jolie" said Dr. Huma Rana, a geneticist at the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute.
Tags: BreastCancer, Prevention
- More than 250 women business and community leaders will gather for the fifth Susan. F. Smith Center for Women's Cancers Executive Council, Beyond Boston Luncheon. The luncheon will include a panel discussion led by Eric P. Winer.
Tags: BreastCancer, CervicalCancer, OvarianCancer, GynecologicCancers
- Research led by Dr. Ann Partridge shows young women with breast cancer who are of poorer financial status may experience delays in seeking medical care and advice for the disease.
Tags: BreastCancer, Disparities
- Dr. Mehra Golshan said Angelina Jolie's decision to get a double mastectomy might help save lives by raising awareness about the need for genetic testing.
Tags: BreastCancer, Genetics
- For women 40 and older, the American Cancer Society recommends annual mammograms, but Dr. Ann Partridge says mammograms don't work as well for young women, who have denser breasts.
- Dr. Ian Krop talks about the new drug Perjeta. The drug was recently approved by the US Food and Drug Administration to shrink breast tumors before surgery.
Tags: BasicResearch, BreastCancer